¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2023³â Á¦3ȸ ´ëÇѳúÇ÷°ü¿Ü°úÇÐȸ ¸ð¾ß¸ð¾ßº´ Çмú´ëȸ : 2023-07-07

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2023³â Á¦3ȸ ´ëÇѳúÇ÷°ü¿Ü°úÇÐȸ ¸ð¾ß¸ð¾ßº´ Çмú´ëȸ : 2023-07-07
±³À°ÀÏÀÚ : 2023-07-07
±³À°Àå¼Ò : ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ

±³À°ÁÖÁ¦ : 2023³â Á¦3ȸ ´ëÇѳúÇ÷°ü¿Ü°úÇÐȸ ¸ð¾ß¸ð¾ßº´ Çмú´ëȸ

ÁÖÃÖ±â°ü : ´ëÇѳúÇ÷°ü¿Ü°úÇÐȸ
´ã´çÀÚ : Á¤È¿°æ
¿¬¶ôó : 02-2279-9560  

À̸ÞÀÏ : kscvs@hanmail.net

±³À°Á¾·ù : ½Å°æ¿Ü°ú

Âü¼®¿¹»óÀÎ : 30¸í
Èñ¸ÁÆòÁ¡ : 3Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 4 ½Ã°£ 30ºÐ

¼¼ºÎ¼ö°­·á : 0¿ø  

ºñ°í ¹«·á


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 07¿ù 07ÀÏ ¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ 14:00~15:00 Specific Issues in Moyamoya Disease - Optimization of recipient artery in revasculizationsurgery for moyamoya disease ¿¬Á¦¿µ(¼º±Õ°ü´ë »ï¼º¼­¿ïº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 07¿ù 07ÀÏ ¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ 15:00~16:00 Specific Issues in Moyamoya Disease - Pregnancy and heredity in patients with moyamoya disease À̽ÿî(ºÐ´ç¼­¿ï´ëº´¿ø ½Å°æ¿Ü°ú)

ÈÞ½Ä 07¿ù 07ÀÏ ¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ 16:00~16:30 ÈÞ½Ä ()

±³À°½Ã°£ 07¿ù 07ÀÏ ¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ 16:30~16:45 Case Presentation - 1. A Case Report : Development of a new ant.choroidal aneurysm following EDAS in a hemorrhagic Moyamoya patient ÀºÁø(°¡Å縯´ë ÀºÆò¼º¸ðº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 07¿ù 07ÀÏ ¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ 16:45~17:00 Case Presentation - 2. Ruptured aneurysm in moyamoya disease ¿ÀÀç»ó(°¡Å縯´ë ÀÇÁ¤ºÎ¼º¸ðº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 07¿ù 07ÀÏ ¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ 17:00~17:15 Case Presentation - 3. Two cases of complications during bypass surgery for MMS À̼ºÈ£(¼­¿ï´ëº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 07¿ù 07ÀÏ ¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ 17:15~17:30 Case Presentation - 4. Hyperperfusion Syndrome after Triple-Barreled STA-RAG-A1 and STA-MCA Bypass in Moyamoya Angiopathy À嵿±Ô(°¡Å縯´ë ÀÎõ¼º¸ðº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 07¿ù 07ÀÏ ¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ 17:30~17:45 Case Presentation - 5. Transient neurological deterioration due to watershed shift after STA-MCA bypass surgery in Moyamoya disease ÁöűÙ(¼º±Õ°ü´ë »ï¼º¼­¿ïº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 07¿ù 07ÀÏ ¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ 17:45~18:00 Case Presentation - 6. Post OP Delayed ICH due to hyperperfusion after combined bypass surgery to MMD patient ÀÌ»óÈ¿(ºÐ´ç¼­¿ï´ëº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 07¿ù 07ÀÏ ¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ 18:00~18:15 Case Presentation - 7. Mortality case due to postoperative cerebral infarction following bypass surgery in a moyamoya patient ÃÖÁØÈ£(¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 07¿ù 07ÀÏ ¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ 18:15~18:30 Case Presentation - 8. Hydration-induced rapid growth and regression after indirect revascularization of an anterior choroidal artery aneurysm associated with Moyamoya disease: A case report ±èÀåÈÆ(°í·Á´ë ¾È¾Ïº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 07¿ù 07ÀÏ ¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ 18:30~18:45 Case Presentation - 9. Prediction of contralateral progression in nonhemorrhagic moyamoya disease after unilateral surgery ¹æâȯ(Áß¾Ó´ë ±¤¸íº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 07¿ù 07ÀÏ ¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ 18:45~19:00 Case Presentation - 10. Cerebral autoregulatory dysfunction as a main pathophysiology of postoperative cerebral hyperperfusion syndrome in adult moyamoya disease Á¶¿ø»ó(¼­¿ï´ëº´¿ø ½Å°æ¿Ü°ú)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2023³â Á¦3ȸ ´ëÇѳúÇ÷°ü¿Ü°úÇÐȸ ¸ð¾ß¸ð¾ßº´ Çмú´ëȸ : 2023-07-07""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦20ȸ ½É±Ù°æ»ö¿¬±¸È¸ ÇÏ°è ½ÉÆ÷Áö¾ö(1ÀÏÂ÷) : 2023-07-07
´ÙÀ½±Û ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø Current status and Challenages of Coronary artery disease and Aortic valvular heart disease : 2023-07-06
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20730 °­¿ø 2024³â °³¿øÀǸ¦ À§ÇÑ ³»°úÇÐ ¿¬¼ö°­Á : 2024-06-02 0 4 2024-05-27
20729 Ãæ³² Á¦16Â÷ Ä¡¸ÅÁø·áÀÇ»ç Àü¹®È­ ±³À° (»ó¹Ý±â_3ÀÏÂ÷) : 2024-06-02 0 22 2024-05-27
20728 ¼­¿ï 2024³â ´ëÇÑÀÇÇз¹ÀÌÀúÇÐȸ Á¦13Â÷ ¿¬¼ö±³À° : 2024-06-02 0 11 2024-05-27
20727 ¼­¿ï Á¦9ȸ °¡Á¤ÀÇ, È£½ºÇǽº ¿ÏÈ­ÀÇ·á Àü¹®°¡µÇ±â : 2024-06-01 0 10 2024-05-27
20726 ¼­¿ï ÀÌ´ë¼­¿ïº´¿ø »êºÎÀΰú Áö¿ªÀÇ»ç °£´ãȸ(Àӽżº °íÇ÷¾Ð ÁúȯÀÇ Á¶±â ¿¹Ãø°ú ¿¹¹æ) : 2024-06-01 0 51 2024-05-27
20725 ¼­¿ï Çѱ¹Á¤½ÅÄ¡·áÇÐȸ Á¤½ÅÄ¡·á Áõ·Ê¹ßÇ¥(ÀÚ±â¾ÖÀû ÀΰÝÀå¾Ö) : 2024-06-01 0 3 2024-05-27
20724 ¼­¿ï °Ç±¹´ëÇб³º´¿ø ´ëÇÑÀÇÁø±ÕÇÐȸ Á¦30Â÷ Çмú´ëȸ : 2024-06-01 0 5 2024-05-27
20723 ¼­¿ï Á¦54Â÷ ´ëÇѼҾƽŰæ¹ß´ÞÇൿ¿¬±¸È¸ ÇмúÁý´ãȸ : 2024-06-01 0 8 2024-05-27
20722 °æ³² Á¦25ȸ °æ³²ÀÇ»çÀÇ ³¯ ±â³ä Á¾ÇÕÇмú´ëȸ[¿Â.¿ÀÇÁ¶óÀÎ µ¿½Ã °³ÃÖ] : 2024-06-01 0 48 2024-05-27
20721 ÀüºÏ 2024³â ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ÀüºÏÁöȸ Á¦12ȸ ¿¬¼ö°­Á : 2024-06-01 0 63 2024-05-27
20720 ¼­¿ï 2023³â Á¦7Â÷ ³»°úºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À° : 2024-06-01 0 39 2024-05-26
20719 ºÎ»ê Á¦516Â÷ ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ ºÎ»ê¡¤¿ï»ê¡¤°æ³²Áöȸ Çмú´ëȸ : 2024-06-01 0 48 2024-05-26
20718 °æ±â Àü¹®½ÉÀå¼Ò»ý¼ú(ACLS Provider) ½Ã¹Ä·¹À̼Ç(2day) : 2024-06-01 0 29 2024-05-26
20717 Ãæ³² Á¦16Â÷ Ä¡¸ÅÁø·áÀÇ»ç Àü¹®È­ ±³À° (»ó¹Ý±â_2ÀÏÂ÷) : 2024-06-01 0 42 2024-05-26
20716 ¼­¿ï 2024 ´ëÇѵΰæºÎ¿Ü°úÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-01 0 24 2024-05-26
11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷